At the molecular level, classic complement factors C1QB and C1QC were significantly upregulated in the plasma exosomes of DM and polymyositis (PM) patients compared to those isolated from healthy control plasma, implicating the complement in the immunopathogenesis of DM/PM as a mediator of microvascular damage and muscle weakness [87]. This evidence concerns the gene C1QB and diabetes mellitus.